Cryopreservation Clinical Trial
Various morphological abnormalities of human oocytes were reported to detrimentally affect embryo development. We observed development of frozen thawed embryos derived from oocytes with normal or abnormal morphological features to the blastocyst stage. Cytoplasmic abnormalities of the oocytes were found to negatively affect cryosurvival potential of the embryos.
n/a
Observational Model: Defined Population, Time Perspective: Longitudinal
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02032797 -
Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.
|
Phase 4 | |
Recruiting |
NCT03913208 -
Priority to Cryopreservation Strategy (PCS) in IVF-ICSI Cycles
|
N/A | |
Completed |
NCT04011813 -
Hypotaurine Supplementation Benefits in Cryopreservation
|
||
Recruiting |
NCT06261658 -
Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma
|
N/A | |
Completed |
NCT04487639 -
Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ?
|
N/A | |
Completed |
NCT06448000 -
Effect of Long-time Human Sperm Storage in Liquid Nitrogen on Semen Parameters
|
||
Withdrawn |
NCT02687880 -
Testicular Tissue Cryopreservation for Fertility Preservation in Male Patients Facing Infertility-causing Diseases or Treatment Regimens
|
||
Completed |
NCT03153436 -
The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation
|
Phase 1/Phase 2 |